Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
Scientists test if 'Cleaned' blood stays safe in patients
Disease control Not yet recruitingThis study is testing a special type of treated red blood cells designed to be safer from pathogens. Researchers want to see if patients who already have antibodies to these treated cells have bad reactions or clear the cells too fast after a transfusion. They will compare these …
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Race against time: new Blood-Clotting treatment aims to stop trauma bleeding faster
Disease control Not yet recruitingThis study aims to see if a new, shelf-stable blood-clotting treatment (IFC) can be given faster than the standard treatment (Cryo-AHF) to people with severe bleeding after a traumatic injury. It will involve 320 adults arriving at trauma centers with life-threatening blood loss …
Sponsor: Cerus Corporation • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Scientists track special blood cells in sickle cell patients
Knowledge-focused Not yet recruitingThis study aims to understand how long specially treated, pathogen-reduced red blood cells last in the body of adults with sickle cell disease. It will follow five patients who regularly receive blood exchange therapy, tracking the treated cells with special markers. The goal is …
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC